Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis

Clinical and Experimental Immunology

Volumn 143, Issue 2, 2006, Pages 357-362

  Sanna, A ^a   Fois, M L ^a   Arru, G ^a   Huang, Y M ^b   Link, H ^b   Pugliatti, M ^a   Rosati, G ^a   Sotgiu, S ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cytokines; Dendritic cells; Glatiramer acetate; Lymphocytes; Multiple sclerosis

Indexed keywords

GLATIRAMER; INTERLEUKIN 13; INTERLEUKIN 5; MYELIN BASIC PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 4; INTERLEUKIN DERIVATIVE; PEPTIDE;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COCULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG ACTIVITY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; TH2 CELL; CELL DIVISION; CULTURE MEDIUM; DRUG EFFECT; IMMUNOLOGY; METHODOLOGY; MIXED LYMPHOCYTE CULTURE; MONOCYTE;

ADULT; CELL DIVISION; COCULTURE TECHNIQUES; CULTURE MEDIA; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; INTERLEUKINS; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES; MALE; MONOCYTES; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PEPTIDES;

EID: 33644861046     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.02997.x     Document Type: Article

References (22)

1. Olsson T Humanized antibodies against an adhesion molecule block the CNS inflammation in multiple sclerosis Lakartidningen 2003 100 1705
2. Banchereau J Steinman RM Dendritic cells and the control of immunity Nature 1998 392 245 52
3. Kalinski P Hilkens CM Wierenga EA Kapsenberg ML T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal Immunol Today 1999 20 561 7
4. Hilkens CM Kalinski P de Boer M Kapsenberg ML Human dendritic cells require exogenous interleukin-12- inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype Blood 1997 90 1920 6
5. Vieira PL de Jong EC Wierenga EA Kapsenberg ML Kalinski P Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells J Immunol 2003 170 4483 12
6. Kalinski P Hilkens CM Snijders A Snijdewint FG Kapsenberg ML Dendritic cells, obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses Adv Exp Med Biol 1997 417 363 7
7. Pashenkov M Soderstrom M Huang Y-M Link H Cerebrospinal fluid affects phenotype and functions of myeloid dendritic cells Clin Exp Immunol 2002 128 379 87
8. Pashenkov M Teleshova N Link H Inflammation in the central nervous system: the role for dendritic cells Brain Pathol 2003 13 23 33
9. Johnson KP Brooks BR Ford CC et al. Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial Mult Scler 2003 9 585 91
10. Comi G Moviola L Glatiramer acetate Neurologia 2002 17 244 58
11. Paty D Arnason B Li D et al. Interferons in relapsing remitting multiple sclerosis Lancet 2003 361 1822 4
12. Aharoni R Kayhan B Eilam R Sela M Arnon R Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ Proc Natl Acad Sci USA 2003 100 14157 62
13. Neuhaus O Archelos JJ Hartung HP Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection Trends Pharmacol Sci 2003 2 131 8
14. Dhib-Jalbut S Chen M Said A Zhan M Johnson KP Martin R Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype J Neuroimmunol 2003 140 163 71
15. Putheti P Soderstrom M Link H Huang Y-M Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-100 production in multiple sclerosis J Neuroimmunol 2003 144 125 31
16. Rieks M Hoffmann V Aktas O et al. Induction of apoptosis of CD4+ T cells by immunomodulatory therapy of multiple sclerosis with glatiramer acetate Eur Neurol 2003 50 200 6
17. Hussien Y Sanna A Soderstrom M Link H Huang Y-M Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis J Neuroimmunol 2001 121 102 10
18. Vieira PL de Jong EC Wierenga EA Kapsenberg ML Kalinski P Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction J Immunol 2000 164 4507 12
19. Weber MS Starck M Wagenpfeil S Meinl E Hohlfeld R Farina C Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo Brain 2004 127 1370 8
20. Farina C Weber MS Meinl E Wekerle H Hohlfeld R Glatiramer acetate in multiple sclerosis. update on potential mechanisms of action Lancet Neurol 2005 4 567 75
21. Wiesemann E Klatt J Sonmez D Blasczyk R Heidenreich F Windhagen A Glatiramer acetate (GA) induces IL-13/IL-5 secretion in naive T cells J Neuroimmunol 2001 119 137 44
22. Kelly BL Locksley RM Coordinate regulation of the IL-4, IL-13, and IL-5 cytokine cluster in Th2 clones revealed by allelic expression patterns J Immunol 2000 165 2982 6